# A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer

> **NCT07031154** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 43 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Adebrelimab
- Apatinib

## Interventions

- **DRUG:** Adebrelimab
- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT07031154
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07031154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07031154, "A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT07031154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*